These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38940720)

  • 21. Body mass index-percent forced vital capacity-respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients.
    Kishaba T; Nagano H; Nei Y; Yamashiro S
    J Thorac Dis; 2016 Dec; 8(12):3596-3604. PubMed ID: 28149554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gender-Age-Physiology system as a prognostic model in patients with idiopathic pulmonary fibrosis treated with nintedanib: a longitudinal cohort study.
    Abe M; Tsushima K; Yoshioka K; Sakayori M; Suzuki K; Hirasawa Y; Kawasaki T; Ikari J; Terada J; Tatsumi K
    Adv Respir Med; 2020; 88(5):369-376. PubMed ID: 33169806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.
    Tian M; Meng K; Gao Y; Zhang J; Xie M; Tian Y; Liu X; Ma M; Cai Y; Wu H; Ding J; Chen J; Cai H
    Ann Transl Med; 2022 Sep; 10(18):992. PubMed ID: 36267722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical eye on IPF: a cohort study redefining the mortality scenario.
    Tomassetti S; Ravaglia C; Piciucchi S; Ryu J; Wells A; Donati L; Dubini A; Klersy C; Luzzi V; Gori L; Rosi E; Lavorini F; Poletti V
    Front Med (Lausanne); 2023; 10():1151922. PubMed ID: 37332746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors of survival in idiopathic pulmonary fibrosis.
    Kim JH; Lee JH; Ryu YJ; Chang JH
    Tuberc Respir Dis (Seoul); 2012 Sep; 73(3):162-8. PubMed ID: 23166549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental prognostic value of arterial elastance in mild-to-moderate idiopathic pulmonary fibrosis.
    Sonaglioni A; Caminati A; Nicolosi GL; Lombardo M; Harari S
    Int J Cardiovasc Imaging; 2022 Jul; 38(7):1473-1485. PubMed ID: 35103898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated airway quantification associates with mortality in idiopathic pulmonary fibrosis.
    Cheung WK; Pakzad A; Mogulkoc N; Needleman S; Rangelov B; Gudmundsson E; Zhao A; Abbas M; McLaverty D; Asimakopoulos D; Chapman R; Savas R; Janes SM; Hu Y; Alexander DC; Hurst JR; Jacob J
    Eur Radiol; 2023 Nov; 33(11):8228-8238. PubMed ID: 37505249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prognostic factors in idiopathic pulmonary fibrosis in a tunisian cohort].
    Touil I; Keskes Boudawara N; Bouchareb S; Ben Saad A; Migaou A; Cheikh Mhamed S; Fahem N; Mribah H; Knani J; Boussoffara L; Rouatbi N; Joobeur S
    Rev Mal Respir; 2021 Sep; 38(7):681-688. PubMed ID: 33992493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
    Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting.
    Santos G; Fabiano A; Mota PC; Rodrigues I; Carvalho D; Melo N; Novais-Bastos H; Alexandre AT; Moura CS; Guimarães S; Pereira JM; Carvalho A; Morais A
    Pulm Pharmacol Ther; 2023 Dec; 83():102261. PubMed ID: 37758002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis.
    Mooney J; Reddy SR; Chang E; Broder MS; Gokhale S; Corral M
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1724-1733. PubMed ID: 34818092
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiological and Physiological Predictors of IPF Mortality.
    Kishaba T; Maeda A; Yamazato S; Nabeya D; Yamashiro S; Nagano H
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684158
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kataoka K; Ogawa T; Watanabe F; Arizono S
    Eur Respir J; 2010 Nov; 36(5):1067-72. PubMed ID: 20413545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary Fibrosis.
    Colombi D; Ehlers-Tenenbaum S; Palmowski K; Heussel CP; Sverzellati N; Silva M; Eichinger M; Kreuter M
    Respiration; 2016; 92(1):25-33. PubMed ID: 27348534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis.
    Sridhar M; Bodduluri S; O'Hare L; Blumhoff S; Acosta Lara MDP; de Andrade JA; Kim YI; Luckhardt T; McDonald M; Kulkarni T
    Respir Res; 2024 Feb; 25(1):81. PubMed ID: 38326848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.
    Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park SW; Park MS
    Respir Res; 2016 Oct; 17(1):131. PubMed ID: 27756398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multidimensional index and staging system for idiopathic pulmonary fibrosis.
    Ley B; Ryerson CJ; Vittinghoff E; Ryu JH; Tomassetti S; Lee JS; Poletti V; Buccioli M; Elicker BM; Jones KD; King TE; Collard HR
    Ann Intern Med; 2012 May; 156(10):684-91. PubMed ID: 22586007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.